Treatment of viral retinitis after allogeneic hematopoietic stem cell transplantation with maribavir: A report of three cases and a review of the literature
Transplant Immunology · 2026-12 · 99 · 102469
DOI: 10.1016/j.trim.2026.102469 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transplant Immunology, 2026-12. Verfasst von Yunfeng Shi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, the First Affiliated Hospital of Xi'an Jiaotong University, 710061 Xi'an, China. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Viral retinitis subsequent to allogeneic hematopoietic stem cell transplantation (allo - HSCT) is a severe post - transplant ocular complication. This study presents data on three patients who developed viral retinitis after allo - HSCT. All three patients received letermovir and acyclovir prophylaxis for cytomegalovirus (CMV) or other viral infections post - transplantation. They exhibited Epstein - Barr (EB) virus and/or CMV viremia and were associated with post - transplant lymphoproliferative disorders, which improved after rituximab therapy. Viral retinitis was diagnosed during immunosuppressive therapy (7-8 months post - transplantation), with negative peripheral blood viral DNA quantification at the time of diagnosis. Intravitreal injection of ganciclovir or foscarnet sodium demonstrated suboptimal efficacy, whereas visual improvement was achieved through combined oral antiviral therapy using maribavir. These findings imply that enhanced vigilance for viral retinitis and intensified fundus monitoring are necessary for patients with prior CMV or EB virus viremia during letermovir prophylaxis for CMV. Intravitreal injection combined with oral maribavir represents a novel therapeutic approach for patients with suboptimal responses to ganciclovir or foscarnet sodium.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, the First Affiliated Hospital of Xi'an Jiaotong University, 710061 Xi'an, China.
- Department of Hematology, the First Affiliated Hospital of Xi'an Jiaotong University, 710061 Xi'an, China. Electronic address: wangxn99@163.com.
Zitieren
APA
Shi, Y., & Wang, X. (2026). Treatment of viral retinitis after allogeneic hematopoietic stem cell transplantation with maribavir: A report of three cases and a review of the literature. Transplant Immunology, 99, 102469. https://doi.org/10.1016/j.trim.2026.102469
Vancouver
Shi Y, Wang X. Treatment of viral retinitis after allogeneic hematopoietic stem cell transplantation with maribavir: A report of three cases and a review of the literature. Transplant Immunology. 2026;99:102469. doi:10.1016/j.trim.2026.102469
BibTeX
@article{Shi2026,
author = {Shi, Yunfeng and Wang, Xiaoning},
title = {Treatment of viral retinitis after allogeneic hematopoietic stem cell transplantation with maribavir: A report of three cases and a review of the literature},
journal = {Transplant Immunology},
year = {2026},
volume = {99},
pages = {102469},
doi = {10.1016/j.trim.2026.102469}
}
EUVIMED